Michael Daunov
Cleveland, OHNPI 1841796372
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations.
Across 84 payments — averaging $22.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$265
- Pfizer$157
- Novartis$154
- Takeda Pharmaceuticals U.S.A., Inc.$153
- AstraZeneca$133
- Blueprint Medicines Corporation$114
- plus $927 from 21 others
What the payments were for
- Food & beverage$1,902100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 8 | $265 |
| Pfizer | 8 | $157 |
| Novartis | 8 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $153 |
| AstraZeneca(2 entities) | 6 | $133 |
| Blueprint Medicines Corporation | 4 | $114 |
| Merck | 5 | $91 |
| Daiichi Sankyo Inc. | 3 | $83 |
| Incyte Corporation | 4 | $81 |
| Eisai Inc. | 4 | $78 |
| Beone Medicines USA, Inc. | 2 | $65 |
| ADC Therapeutics America, Inc. | 3 | $58 |
| Bristol Myers Squibb | 3 | $52 |
| Seagen Inc. | 3 | $51 |
| Genmab U.S., Inc. | 2 | $46 |
| AbbVie | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| Gilead(2 entities) | 2 | $36 |
| Astellas Pharma US Inc | 1 | $31 |
| Lilly USA, LLC | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Agios Pharmaceuticals, Inc. | 1 | $25 |
| Amgen | 1 | $24 |
| Sobi, Inc | 1 | $20 |
| Array Biopharma Inc | 1 | $20 |
| Beigene USA, Inc. | 1 | $18 |
| Springworks Therapeutics, Inc. | 1 | $14 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.